Emmanuelle Charpentier speaker

Emmanuelle Charpentier Keynote Speaker

  • Awarded the 2020 Nobel Prize in Chemistry
  • Expert on the transformative CRISPR-Cas9
  • Microbiologist, geneticist and biochemist


Keynote speaker Emmanuelle Charpentier is the recently awarded 2020 Nobel Prize winner in Chemistry along Jennifer Doudna “for the development of a method for genome editing”. Emmanuelle is a French microbiologist, geneticist and biochemist. She received her education in Paris (France) and pursued a scientific career in academic research institutions in Paris, New York and Memphis (United States), Vienna (Austria), Umeå (Sweden) and Braunschweig (Germany). Emmanuelle is now based in Berlin (Germany).  Emmanuelle is a popular speaker on a range of issues including science and technology.

Emmanuelle has focused most of her scientific career on the understanding of fundamental mechanisms of diseases with a particular focus on infections caused by Gram-positive bacterial pathogens such as Listeria, staphylococci and streptococci.

Emmanuelle is mainly recognised for her and her lab’s research on the CRISPR-Cas9 adaptive immune system in the human pathogen Streptococcus pyogenes and other bacterial species that has laid the foundation for the development of a novel, highly versatile and specific genome editing and engineering technology. The so-called CRISPR-Cas technology is revolutionizing life sciences research. CRISPR-Cas has opened whole new opportunities in biotechnologies and in biomedical gene therapies that are impacting society and humanity. The field of CRISPR-Cas biology and engineering continues to develop at dazzling speed, with exciting new developments still emerging almost weekly.

For her and her team’s contributions to the so-called CRISPR-Cas9 discovery, speaker Emmanuelle Charpentier has received numerous honors, decorations, prizes, awards and honorary doctorate degrees from Europe, Asia and North America. She is elected member of national and international scientific academies.

Emmanuelle is inventor and co-owner of the fundamental intellectual property comprising the CRISPR-Cas9 technology. Together with Rodger Novak and Shaun Foy, she co-founded CRISPR Therapeutics and ERS Genomics with the aim to develop the CRISPR-Cas genome engineering technology for biotechnological and biomedical applications.

Read More

Videos of Emmanuelle Charpentier

80th Symposium - 21st Century Genetics: Genes at Work - Emmanuelle Charpentier
80th Symposium - 21st Century Genetics: Genes at Work - Emmanuelle Charpentier
Emmanuelle Charpentier founder of the CRISPR-Cas9 gene editing technology
Emmanuelle Charpentier founder of the CRISPR-Cas9 gene editing technology

Check Emmanuelle Charpentier's speaking availability and fees

Interested in booking Emmanuelle Charpentier to speak at an event? Please provide your details and we’ll get in touch within 24 hours.

    View our related Speakers

    Ann Romney Speaker
    Ann Romney
    Best-selling Author & Former First Lady of Massachusetts
    Jeffrey Hollender Speaker
    Jeffrey Hollender
    Corporate Responsibility & Sustainability Expert
    Clint Laurent Speaker
    Clint Laurent
    Founder, CEO Global Demographics Ltd & Global Demographics Healthcare Ltd
    Raina Kumra Speaker
    Raina Kumra
    Expert on Digital transformation and AI ethics
    Matt Ridley Speaker
    Matt Ridley
    Best-selling Author, "The Rational Optimist"
    Douglas Corley Speaker
    Douglas Corley
    Healthcare Entrepreneur
    Jeremy Hunt Speaker
    Jeremy Hunt
    Longest serving UK Secretary of State for Health
    Alanna Shaikh Speaker
    Alanna Shaikh
    Global Health and Biosecurity Expert
    Jane Metcalfe Speaker
    Jane Metcalfe
    Founder and CEO, NEO.LIFE
    Emily Penn Speaker
    Emily Penn
    Environmental Campaigner

    We use cookies

    We use cookies and other tracking technologies to improve your browsing experience on our website, to show you personalized content and targeted ads, to analyze our website traffic, and to understand where our visitors are coming from. By browsing our website, you consent to our use of cookies and other tracking technologies.

    Accept Cookies